|
1
|
Paus R and Cotsarelis G: The biology of
hair follicles. N Engl J Med. 341:491–497. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hardy MH: The secret life of the hair
follicle. Trends Genet. 8:55–61. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stenn KS and Paus R: Controls of hair
follicle cycling. Physiol Rev. 81:449–494. 2001.PubMed/NCBI
|
|
4
|
Nair B and Elmore AR; Cosmetic Ingredient
Review Expert panel: Final report on the safety assessment of human
placental protein, hydrolyzed human placental protein, human
placental enzymes, human placental lipids, human umbilical extract,
placental protein, hydrolyzed placental protein, placental enzymes,
placental lipids, and umbilical extract. Int J Toxicol. 21(Suppl
1): 81–91. 2002. View Article : Google Scholar
|
|
5
|
Shibasaki T, Odagiri E, Shizume K and Ling
N: Corticotropin-releasing factor-like activity in human placental
extracts. J Clin Endocrinol Metab. 55:384–386. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jung J, Lee HJ, Lee JM, Na KH, Hwang SG
and Kim GJ: Placenta extract promote liver regeneration in
CCl4-injured liver rat model. Int Immunopharmacol. 11:976–984.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu KX, Kato Y, Kaku T and Sugiyama Y:
Human placental extract stimulates liver regeneration in rats. Biol
Pharm Bull. 21:44–49. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sur TK, Biswas TK, Ali L and Mukherjee B:
Anti-inflammatory and anti-platelet aggregation activity of human
placental extract. Acta Pharmacol Sin. 24:187–192. 2003.PubMed/NCBI
|
|
9
|
Rosen T, Krikun G, Ma Y, Wang EY, Lockwood
CJ and Guller S: Chronic antagonism of nuclear factor-kappaB
activity in cytoblasts by dexamethasone: a potential mechanismfor
antiinflammatory action of glucocorticoids in human placenta. J
Clin Endocrinol Metab. 83:3647–3652. 1998.PubMed/NCBI
|
|
10
|
Topical minoxidil approved by FDA. Clin
Pharm. 7:8588621988.
|
|
11
|
Rossi A, Cantisani C, Melis L, Iorio A,
Scali E and Calvieri S: Minoxidil use in dermatology, side effects
and recent patents. Recent Pat Inflamm Allergy Drug Discov.
6:130–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Morokuma Y, Yamazaki M, Maeda T, Yoshino
I, Ishizuka M, Tanaka T, Ito Y and Tsuboi R: Hair growth
stimulatory effect by a combination of 5-aminolevulinic acid and
iron ion. Int J Dermatol. 47:1298–1303. 2008. View Article : Google Scholar
|
|
13
|
Rastegar H, Ahmadi Ashtiani H, Aghaei M,
Ehsani A and Barikbin B: Combination of herbal extracts and
platelet-rich plasma induced dermal papilla cell proliferation:
involvement of ERK and Akt pathways. J Cosmet Dermatol. 12:116–122.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Loing E, Lachance R, Ollier V and Hocquaux
M: A new strategy to modulate alopecia using a combination of two
specific and unique ingredients. J Cosmet Sci. 64:45–58.
2013.PubMed/NCBI
|
|
15
|
Chu EY, Hens J, Andl T, Kairo A, Yamaguchi
TP, Brisken C, Glick A, Wysolmerski JJ and Millar SE: Canonical WNT
signaling promotes mammary placode development and is essential for
initiation of mammary gland morphogenesis. Development.
131:4819–4829. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Soma T, Fujiwara S, Shirakata Y, Hashimoto
K and Kishimoto J: Hair-inducing ability of human dermal papilla
cells cultured under Wnt/β-catenin signalling activation. Exp
Dermatol. 21:307–309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Woodgett JR: Judging a protein by more
than its name: GSK-3. Sci STKE. 2001:re122001.PubMed/NCBI
|
|
19
|
Li L, Yuan H, Weaver CD, Mao J, Farr GH
III, Sussman DJ, Jonkers J, Kimelman D and Wu D: Axin and Frat1
interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated
regulation of LEF-1. EMBO J. 18:4233–4240. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jo SJ, Choi SJ, Yoon SY, Lee JY, Park WS,
Park PJ, Kim KH, Eun HC and Kwon O: Valproic acid promotes human
hair growth in in vitro culture model. J Dermatol Sci. 72:16–24.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Philpott MP and Kealey T: Cyclical changes
in rat vibrissa follicles maintained In vitro. J Invest Dermatol.
115:1152–1155. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Handjiski BK, Eichmüller S, Hofmann U,
Czarnetzki BM and Paus R: Alkaline phosphatase activity and
localization during the murine hair cycle. Br J Dermatol.
131:303–310. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kwack MH, Kang BM, Kim MK, Kim JC and Sung
YK: Minoxidil activates β-catenin pathway in human dermal papilla
cells: a possible explanation for its anagen prolongation effect. J
Dermatol Sci. 62:154–159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hwang KA, Hwang YL, Lee MH, Kim NR, Roh
SS, Lee Y, Kim CD, Lee JH and Choi KC: Adenosine stimulates growth
of dermal papilla and lengthens the anagen phase by increasing the
cysteine level via fibroblast growth factors 2 and 7 in an organ
culture of mouse vibrissae hair follicles. Int J Mol Med.
29:195–201. 2012.
|
|
25
|
Yoon SY, Yoon JS, Jo SJ, Shin CY, Shin JY,
Kim JI, Kwon O and Kim KH: A role of placental growth factor in
hair growth. J Dermatol Sci. 74:125–134. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Abdullah F and Rashid RM: Alopecia:
Botanical approaches in review. J Drugs Dermatol. 9:537–541.
2010.PubMed/NCBI
|
|
27
|
Frankel S: Study of the food and drug
administration files on Propecia: dosages, side effects, and
recommendations. Arch Dermatol. 135:257–258. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Irwig MS and Kolukula S: Persistent sexual
side effects of finas-teride for male pattern hair loss. J Sex Med.
8:1747–1753. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Trüeb RM: Chemotherapy-induced hair loss.
Skin Therapy Lett. 15:5–7. 2010.PubMed/NCBI
|
|
30
|
Lourith N and Kanlayavattanakul M: Hair
loss and herbs for treatment. J Cosmet Dermatol. 12:210–222. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rahmani M, Wong BW, Ang L, Cheung CC,
Carthy JM, Walinski H and McManus BM: Versican: signaling to
transcriptional control pathways. Can J Physiol Pharmacol.
84:77–92. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
du Cros DL, LeBaron RG and Couchman JR:
Association of versican with dermal matrices and its potential role
in hair follicle development and cycling. J Invest Dermatol.
105:426–431. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wight TN: Arterial remodeling in vascular
disease: a key role for hyaluronan and versican. Front Biosci.
13:4933–4937. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang Y, Li Y, Wang Y, Wu J, Yang G, Yang
T, Gao Y and Lu Y: Versican gene: regulation by the β-catenin
signaling pathway plays a significant role in dermal papilla cell
aggregative growth. J Dermatol Sci. 68:157–163. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lee SH, Yoon J, Shin SH, Zahoor M, Kim HJ,
Park PJ, Park WS, Min S, Kim HY and Choi KY: Valproic acid induces
hair regeneration in murine model and activates alkaline
phosphatase activity in human dermal papilla cells. PLoS One.
7:e341522012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hibino T and Nishiyama T: Role of
TGF-beta2 in the human hair cycle. J Dermatol Sci. 35:9–18. 2004.
View Article : Google Scholar : PubMed/NCBI
|
